Congress brings knife to CFPB gun fight

CFPB Director Richard Cordray once again sat before Senate in his semi-annual report to Congress, but this time was different. Director Cordray came to battle with an army of supporters, keeping the atmosphere in the room extremely calm compared to previous years, with barely any talk surrounding mortgages. …read more

From:: Real Estate Wire

Lew criticizes MetLife ruling but doesn’t commit to appear

WASHINGTON (MarketWatch) – Treasury Secretary Jacob Lew on Thursday said he “strongly disagreed” with a federal judge ruling rescinding the government’s determination that MetLife Inc. is a systemically important financial institution. “This decision leaves one of the largest and most highly interconnected financial companies in the world subject to even less oversight than before the financial crisis,” Lew said in a statement. He said Treasury would continue to defend the Financial Stability Oversight Council’s ability to designate nonbank financial companies as systemically important “is a critical tool” to address potential threats to financial stability. “We intend to continue defending vigorously the process and integrity of FSOC’s work, and I am confident that we will prevail,” he said.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Tesla says it has more than 325,000 reservations for Model 3

Tesla Motors Inc. said Thursday it has received more than 325,000 reservations for its Model 3, the mass-market car it unveiled last week. The $1,000 reservations for the car imply about $14 billion in future sales, the company said. Tesla expects to start deliveries of the Model 3 in late 2017. The launch “has been a true grassroots effort,” the company said. Shares of Tesla fell 2% on Thursday, but were looking to end the week up more than 9%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

First 365 by Whole Foods Market to open May 25

The first 365 by Whole Foods Market location will open on May 25 in the Silver Lake section of Los Angeles, according to a Thursday release. The lower-priced complement to the original Whole Foods Market Inc. stores, ‘365’ will offer a number of features including online ordering and delivery through Instacart and partnerships with companies like Allegro Coffee Company. Two more 365 locations will open in 2016 in Bellevue, WA and Portland, OR. Whole Foods has signed 13 leases for 365 by Whole Foods Market locations, the company said in February. Whole Foods shares are up 0.9% in Thursday morning trading, but down 39.5% for the past year. The S&P 500 is down 1% for the past 12 months.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Aeglea BioTherapeutics prices offering below range

Aeglea BioTherapeutics Inc. , a cancer and metabolism biotechnology company, priced its offering at $10 a share early Thursday morning, below its initial price range of $16 to $18. The company increased the number of shares it sold to 5 million from 3.5 million shares to raise about $50 million. The company is also giving the underwriters a 30-day option to buy up to 750,000 additional shares of its stock. UBS Investment Bank, BMO Capital Markets, Wells Fargo acted as joint book-running managers with Needham & Co. acting as co-manager.The company plans to begin trading shares on the Nasdaq Thursday.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Aeglea BioTherapeutics prices offering below range

Aeglea BioTherapeutics Inc. , a cancer and metabolism biotechnology company, priced its offering at $10 a share early Thursday morning, below its initial price range of $16 to $18. The company increased the number of shares it sold to 5 million from 3.5 million shares to raise about $50 million. The company is also giving the underwriters a 30-day option to buy up to 750,000 additional shares of its stock. UBS Investment Bank, BMO Capital Markets, Wells Fargo acted as joint book-running managers with Needham & Co. acting as co-manager.The company plans to begin trading shares on the Nasdaq Thursday.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Aeglea BioTherapeutics prices offering below range

Aeglea BioTherapeutics Inc. , a cancer and metabolism biotechnology company, priced its offering at $10 a share early Thursday morning, below its initial price range of $16 to $18. The company increased the number of shares it sold to 5 million from 3.5 million shares to raise about $50 million. The company is also giving the underwriters a 30-day option to buy up to 750,000 additional shares of its stock. UBS Investment Bank, BMO Capital Markets, Wells Fargo acted as joint book-running managers with Needham & Co. acting as co-manager.The company plans to begin trading shares on the Nasdaq Thursday.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News